Genetic markers and explosive leg-muscle strength in elite Italian soccer players

Journal of Sports Medicine and Physical Fitness

Volumn 52, Issue 3, 2012, Pages 328-334

  Massidda, M ^a   Corrias, L ^a   Ibba, G ^b   Scorcu, M ^b,c   Vona, G ^a   Calo C M ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Cagliari Calcio Spa   (Italy)

^c FMSI CR Sardegna   (Italy)

Author keywords

Genetic markers; Muscle strength; Receptor, bradykinin b2; Soccer; Sports

Indexed keywords

ACE PROTEIN, HUMAN; ACTININ; ACTN3 PROTEIN, HUMAN; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ATHLETIC PERFORMANCE; BIOMECHANICS; CHI SQUARE DISTRIBUTION; EXERCISE TEST; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; ITALY; MALE; MUSCLE STRENGTH; PHYSIOLOGY; REGRESSION ANALYSIS; SKELETAL MUSCLE; SPORT;

ACTININ; ANALYSIS OF VARIANCE; ATHLETIC PERFORMANCE; BIOMECHANICS; CHI-SQUARE DISTRIBUTION; EXERCISE TEST; GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; ITALY; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, BRADYKININ B2; REGRESSION ANALYSIS; SOCCER; YOUNG ADULT;

EID: 84864227675     PISSN: 00224707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Santiago C, Ruiz JR, Muniesa CA, González-Freire M, Gómez-Gallego F, Lucia A. Does the polygenic profile determine the potential for becoming a world-class athlete? Insights from the sport of rowing. Scand J Med Sec Sport 2010;20:e 188-94.
2. Ruiz JR, Arteta D, Buxens A, Artieda M, Gómez-Gallego F, Santiago C et al. Can we identify a power-oriented polygenic profile? J Appl Physiol 2010;108:561-6.
3. Little T, Williams AG. Specificity of acceleration, maximal speed, and agility in professional soccer players. J Strength Cond Res 2005;19:76-8. (Pubitemid 40417257)
4. De Proft E, Cabri J, Dufour W, Clarys J. Strength training and kick performance in soccer players. In: Reilly T, Lees A, Davids K, Murphy WJ, editors. Science and Football. London: E & FN Spon; 1988. p. 108-13.
5. Calò CM, Vona G. Gene polymorphism and elite athletic performance. J Anthropol Sci 2008;86:113-31.
6. Jones A, Montgomery HE, Woods DR. Human performance: a role for the ACE genotype? Exerc Sport Sci Rev 2002;30:184-90. (Pubitemid 35204534)
7. Jones A, Woods DR. Skeletal muscle RAS and exercise performance Int J Biochem Cell Biol 2003;35:855-66. (Pubitemid 36379327)
8. Woods D, Hickman M, Jamshidi Y, Brull D, Vassiliou V, Jones A et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet 2001;108:230-2. (Pubitemid 32293669)
9. Scanavini D, Bernardi F, Castoldi E, Conconi F, Mazzoni G. Increased frequency of the homozygous II ACE genotype in Italian Olympic endurance athletes. Eur J Hum Genet 2002;10:576-7. (Pubitemid 35277288)
10. Rankinen T, Wolfarth B, Simoneau JA, Maier-Lenz D, Rauramaa R, Rivera MA et al. No association between the angiotensin-converting enzyme I/D polymorphism and elite endurance athlete status. J Appl Physiol 2000;88:1571-5. (Pubitemid 30336903)
11. Mayfield RK, Shimojo N, and Jaffa AA. Skeletal muscle kallikrein. Potential role in metabolic regulation. Diabetes 1996;(Suppl 1):S20-S23.
12. Langberg H, Bjorn C, Boushel R, Hellsten Y, Kjaer M. Exerciseinduced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol 2002;542:977-83. (Pubitemid 34947288)
13. Vidal MA, Astroza A, Matus CE, Ehrenfeld, P, Pavicic, F, Sanchez T et al. Kinin B2 receptor-coupled signal transduction in human cultured keratinocytes. J Invest Dermatol 2005;124:178-86. (Pubitemid 40100967)
14. Wicklmayr M, Dietze G, Brunnbauer H, Rett K, Mehnert H. Dosedependent effect of bradykinin on muscular blood flow and glucose uptake in man. Hoppe-Seyler's Zeitschrift für physiologische Chemie 1983;364:831-33. (Pubitemid 13003785)
15. Zhang X, Xie YW, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997;95:176-82. (Pubitemid 27029960)
16. Braun A, Kammerer S, Maier E, Böhme E, Roscher AA. Polymorphisms in the gene for the human B2-bradykinin receptor: new tools in assessing a genetic risk for bradykinin-associated diseases. Immunopharmacology 1996;33:32-35. (Pubitemid 26247894)
17. Williams AG, Dhamrait SS, Wootton PT, Day SH, Hawe E, Payne JR et al. et al. Bradykinin receptor gene variant and human physical performance. J Appl Physiol 2004;96:938-42. (Pubitemid 38248666)
18. Brull D, Dhamrait S, Myerson S, Erdmann J, Woods D, World M et al. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 2001;358:1155-6. (Pubitemid 32971851)
19. Montgomery H, Safari L. Genetic basis of physical fitness. Annu Rev Anthropol 2007;36:391-405. (Pubitemid 350066201)
20. MacArthur DG, North KN. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays 2004;26:786-95. (Pubitemid 38987612)
21. Niemi AK, Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 2005;13:965-69. (Pubitemid 41131745)
22. Massidda M, Vona G, Calò CM. Association Between the ACTN3 R577X Polymorphism and Artistic Gymnastic Performance in Italy. Genet Test MoI Biomarkers 2009;13:377-80.
23. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leem putte M, Hespel P et al. ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics 2007;32:58-63.
24. Eynon N, Alves AJ, Yamin C, Sagiv M, Duarte J A, Oliveira J et al. Is there an ACE ID - ACTN3 R577X polymorphisms interaction that influences sprint performance? Int J Sports Med 2009;30:888-91.
25. Rodríguez-Romo G, Ruiz JR, Santiago C, Fiuza-Luces C, González-Freire M, Gómez-Gallego F et al. Does the ACE I/D polymorphism, alone or in combination with the ACTN3 R577X polymorphism, influence muscle power phenotypes in young, non-athletic adults? Eur J Appl Physiol 2010; 110:1099-106.
26. Bosco C, Luhtanen P, and Komi PV. A simple method for measurement of mechanical power in jumping. Eur J Appl Physiol Occup Physiol 1983;50:273-82. (Pubitemid 13175168)
27. Garganta J, Maia J, Silva R, Natal A. A comparative study of explosive leg strength in elite and non-elite young soccer players. J Sports Sci 1992;10:157.
28. Tsianos G, Sanders J, Dhamrait S, Humphries S, Grant S, Montgomery H et al. The ACE gene insertion/deletion polymorphism and elite endurance swimming. Eur J Appl Physiol 2004;92:360-2. (Pubitemid 39117500)
29. Santiago C, González-Freire M, Serratosa L, Morate FJ, Meyer T, Gómez-Gallego F et al. ACTN3 genotype in professional soccer players. Br J Sports Med 2008;42:71-3. (Pubitemid 351158215)
30. Ruiz JR, Fernández Del Valle M, Verde Z, Diez-Vega I, Santiago C, Yvert T et al. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scand J Med Sci Sports 2010;21:e34-41.
31. Scott RA, Irving R, Irwin L, Morrison E, Charlton V, Austin K et al. ACTN3 and ACE genotypes in elite Jamaican and US sprinters. Med Sci Sports Exerc 2010;42:107-12.
32. Massidda M, Vona G, Calò CM. Lack of association between ACE insertion/deletion polymorphism and elite artistic gymnastic performance in Italians. Eur J Sport Sci 2011;11:149-53.
33. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999;87:1313-6. (Pubitemid 29483113)
34. Hagberg JM, Rankinen T, Loos RJ, Pérusse L, Roth SM, Wolfarth B et al. Advances in exercise, fitness, and performance genomics in 2010. Med Sci Sports Exerc 2011;43:743-52.
35. Williams AG, Folland JP. Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol 2008;586:113-21.
36. Ruiz JR, Gomez-Gallego F, Santiago C, Gonzalez-Freire M, Verde Z, Foster C et al. Is there an optimum endurance polygenic profile? J Physiol 2009;587:1527-34.